Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.29	44.7	120.39	198.05	19.24
Cash & Short-Term Investments	55.29	44.7	120.39	198.05	19.24
Cash Growth	23.68%	-62.87%	-39.22%	929.49%	-60.61%
Other Receivables	2	-	-	-	-
Receivables	2	-	-	-	-
Prepaid Expenses	2.94	3.42	4.11	4.46	1.35
Total Current Assets	60.23	48.13	124.5	202.52	20.59
Property, Plant & Equipment	9.06	11.2	13.06	13.9	14.06
Other Long-Term Assets	1.78	1.6	1.61	1.64	1.66
Total Assets	71.08	60.93	139.17	218.06	36.32
Accounts Payable	2.57	1.05	3.13	3.14	5.44
Accrued Expenses	9.98	10.5	10.33	8.75	13.73
Current Portion of Long-Term Debt	-	3.32	6.67	-	2.33
Current Portion of Leases	1.19	1.1	1	0.88	0.65
Current Unearned Revenue	13.52	-	-	-	-
Total Current Liabilities	27.26	15.96	21.12	12.78	22.16
Long-Term Debt	-	-	3.17	9.63	7.81
Long-Term Leases	6.95	8.14	9.23	10.23	11.1
Long-Term Unearned Revenue	19.26	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.54
Total Liabilities	53.48	24.1	33.52	32.63	41.6
Common Stock	0.01	0	0	0	-
Additional Paid-In Capital	401.35	362.34	354.75	346.31	1.8
Retained Earnings	-383.75	-325.51	-249.11	-160.89	-85.09
Total Common Equity	17.6	36.83	105.65	185.43	-83.29
Shareholders' Equity	17.6	36.83	105.65	185.43	-5.29
Total Liabilities & Equity	71.08	60.93	139.17	218.06	36.32
Total Debt	8.14	12.55	20.07	20.74	21.89
Net Cash (Debt)	47.15	32.15	100.32	177.32	-2.65
Net Cash Growth	46.64%	-67.95%	-43.42%	-	-
Net Cash Per Share	0.88	1.17	3.66	31.63	-5.06
Filing Date Shares Outstanding	51.77	34.47	27.43	27.36	0.81
Total Common Shares Outstanding	45.76	27.61	27.43	27.36	0.81
Working Capital	32.97	32.17	103.38	189.74	-1.57
Book Value Per Share	0.38	1.33	3.85	6.78	-103.39
Tangible Book Value	17.6	36.83	105.65	185.43	-83.29
Tangible Book Value Per Share	0.38	1.33	3.85	6.78	-103.39
Machinery	6.78	6.68	6.45	4.67	3.64
Construction In Progress	-	-	0.1	0.54	-
Leasehold Improvements	5.12	5.12	5.12	5.12	5.09

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q